We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Convalescent Plasma Improves COVID-19 Survival Rates

By HospiMedica International staff writers
Posted on 29 Jun 2020
Print article
A new study suggests that using plasma from convalescent COVID-19 patients is safe, effective, and improves the chances of survival among those who are severely ill.

Researchers at the Mayo Clinic (Rochester, MN, USA), Michigan State University (MSU; East Lansing, USA), and other institutions conducted a study involving 20,000 patients over the age of 18 years who were confirmed with SARS-CoV-2 infection. The patients were administered ABO compatible convalescent plasma donated by recently-recovered COVID-19 survivors. The treatment involved intravenous administration of 200-500 ml of convalescent plasma. Patients were assessed for improvement at four hours and seven-days after the transfusion of the plasma.

The results revealed that the incidence of all serious adverse events was low; these included transfusion reactions, thromboembolic or thrombotic events (both less than 1%), and cardiac events (3%), which were mostly judged to be unrelated to the plasma transfusion per se. Seven-day mortality was 8.6%, and was higher among more critically-ill patients, including those admitted to the intensive care unit (ICU) 10.5%), the mechanically ventilated (12.1%), and those with septic shock or multiple organ dysfunction or failure (14%). The study was published in on June 20, 2002, in Mayo Clinical Proceedings.

“It is remarkable that there was no system in place for convalescent plasma use in March 2020, and yet within months, the nation is now able to meet most of the demand, despite complex logistics,” concluded lead author Michael Joyner, MD, of the Mayo Clinic, and colleagues. “These updated data provide robust evidence that transfusion of convalescent plasma is safe in hospitalized patients with COVID-19, and support the notion that earlier administration of plasma within the clinical course of COVID-19 is more likely to reduce mortality.”

The use of convalescent plasma is an interim approach until availability of hyperimmune globulin, drug therapies, and vaccines, as the vast majority of patients who recover from COVID-19 develop some level of neutralizing antibodies to SARS-CoV-2 proteins 2-3 weeks following infection. Collecting convalescent plasma from previously infected individuals to passively-transfer antibodies in order to protect or treat human beings dates back almost 100 years, with some evidence for benefit against rabies, hepatitis B, polio, measles, influenza, Ebola and other pathogens.

Related Links:
Mayo Clinic
Michigan State University


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Digital ECG Machine
ECG – 11D

Print article

Channels

Surgical Techniques

view channel
Image: The Early Bird Bleed Monitoring System provides visual and audible indicators of the onset and progression of bleeding events (Photo courtesy of Saranas)

Novel Technology Monitors and Lowers Bleeding Complications in Patients Undergoing Heart Procedures

Bleeding complications at the femoral access site can significantly hamper recovery, affecting the success of procedures, patient satisfaction, and overall healthcare costs. It is crucial for surgeons... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.